Published in J Intercult Ethnopharmacol on March 24, 2016
The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci (2012) 1.65
Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol (2013) 1.24
Viral interference with innate immunity by preventing NF-κB activity. Cell Microbiol (2011) 1.03
Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2. Br J Pharmacol (2013) 1.02
Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects (Review). Exp Ther Med (2015) 0.96
Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. FEBS Lett (1997) 0.96
Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins. Cell Res (2009) 0.92
Antiviral properties of caffeic acid phenethyl ester and its potential application. J Intercult Ethnopharmacol (2015) 0.86
Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus. PLoS One (2013) 0.83
Individual interferon regulatory factor-3 thiol residues are not critical for its activation following virus infection. J Interferon Cytokine Res (2012) 0.82